ATR
AptarGroup, Inc.
Set alert
- YTD
- +12.50%
- 1 year
- +10.32%
- Open
- 138.59
- Prev close
- 130.64
- Mkt cap
- 8.72B
- Vol
- 1.01M
- Avg vol
- 454.75K
- EPS
- 5.54
- P/E
- 24.77
- Div yield
- 1.47%
More statistics
- Low
- 135.52
- High
- 142.31
- Forward P/E
- 22.20
- Beta
- 0.34
- Short ratio
- 4.15
- Inst. own
- 97.90%
- Dividend
- 1.92
- Ex-div date
- Jul 29, 2026
- Earnings
- Feb 4, 2027
- 50-d avg
- 125.78
- 200-d avg
- 126.89
- 1y target
- 162.25
Key statistics
- Market cap
- 8.72B
- Enterprise value
- 9.57B
- Trailing P/E
- 24.76
- Forward P/E
- 22.20
- PEG ratio
- 2.91
- Price / sales
- 2.22
- Price / book
- 3.32
- EPS (TTM)
- 5.54
- Beta
- 0.34
- Dividend yield
- 1.47%
- Payout ratio
- 34.12%
- Profit margin
- 9.22%
- Revenue (TTM)
- 3.93B
- Revenue growth
- 6.30%
- Free cash flow
- 265.98M
- Total cash
- 197.27M
- Total debt
- 1.41B
- Return on equity
- 13.46%
- Shares outstanding
- 63.58M
- Short % of float
- 3.70%
- 50-day average
- 125.78
- 200-day average
- 126.89
Analyst view
Consensus: buy
- Target (low)
- 135.00
- Target (mean)
- 162.25
- Target (high)
- 220.00
- Strong buy2
- Buy5
- Hold2
- Sell0
- Strong sell0
Next earnings
Feb 4, 2027
Expected Feb 4, 2027. Consensus EPS estimate 1.41.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 4, 2027 | Dec 30, 2026 | 1.38 | — | — | — |
| Oct 29, 2026 | Sep 30, 2026 | 1.47 | 1.52 | +0.05 | +3.40% |
| Jul 30, 2026 | Jun 30, 2026 | 1.35 | 1.42 | +0.07 | +5.19% |
| Apr 30, 2026 | Mar 31, 2026 | 1.15 | 1.19 | +0.04 | +3.48% |
| Feb 5, 2026 | Dec 31, 2025 | 1.24 | 1.25 | +0.01 | +0.81% |
| Oct 30, 2025 | Sep 30, 2025 | 1.57 | 1.62 | +0.05 | +3.18% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 9, 2026 | UBS | init | — | Neutral |
| Aug 3, 2026 | Wells Fargo | main | Overweight | Overweight |
| May 4, 2026 | Wells Fargo | main | Overweight | Overweight |
| Mar 20, 2026 | Wells Fargo | up | Equal-Weight | Overweight |
| Jan 6, 2026 | Wells Fargo | down | Overweight | Equal-Weight |
| Nov 3, 2025 | Wells Fargo | main | Overweight | Overweight |
About AptarGroup, Inc.
AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- aptar.com
News
- Dividend Champion, Contender, And Challenger Highlights: Week November 1
- AptarGroup, Inc. (ATR) Q3 2026 Earnings Call Transcript
- What AptarGroup (ATR) Said on Its Q3 Earnings Call
- AptarGroup Q3 2026 Earnings Call Transcript
- AptarGroup (ATR) Q3 Earnings and Revenues Beat Estimates
- AptarGroup Raises Quarterly Cash Dividend From $0.48 To $0.50 Per Share
- Aptar Reports Third Quarter 2026 Results
- Aptar Increases Quarterly Dividend to $0.50 Per Share
- Rakovina Therapeutics and Celvion Therapeutics Complete AI Analysis Identifying Priority Cancer Indications for Brain-Penetrant ATR Inhibitor Program
- AptarGroup's Pharma Unit Partners With Stevanato Group To Provide System-Level Data Supporting Earlier Evaluation Of Pre-Filled Syringe Configurations
Your note
Sign in to keep a note on ATR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ACKERMAN DANIEL | Officer | Stock Award(Grant) | Apr 30, 2026 | 32,779 |
| GONG XIANGWEI | Officer | Sale | May 25, 2026 | 11,416 |
| KANU VANESSA | Chief Financial Officer | Stock Award(Grant) | Mar 18, 2026 | 13,686 |
| OWENS B CRAIG | Director | Stock Award(Grant) | Jul 15, 2026 | 11,233 |
| PRIEUR MARC | Officer | Sale | Aug 3, 2026 | 15,823 |
| TANDA STEPHAN B | Chief Executive Officer | Conversion of Exercise of derivative security | Aug 2, 2026 | 241,879 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 9.65% | 6,137,894 | 841.84M | Jun 29, 2026 |
| State Farm Mutual Automobile Insurance Co | 7.46% | 4,744,564 | 650.74M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.72% | 3,638,724 | 499.07M | Jun 29, 2026 |
| Morgan Stanley | 5.54% | 3,523,908 | 483.32M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.55% | 2,893,751 | 396.89M | Jun 29, 2026 |
| State Street Corporation | 4.50% | 2,863,390 | 392.73M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 2,264,781 | 310.63M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.19% | 2,026,121 | 277.89M | Jun 29, 2026 |
| Victory Portfolios-Victory Sycamore Established Value Fund | 2.92% | 1,858,000 | 254.83M | Jun 29, 2026 |
| Eaton Vance Growth Trust-Eaton Vance Atlanta Capital SMID-Cap Fund | 2.73% | 1,732,643 | 237.64M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.30% | 1,464,114 | 200.81M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 1.46% | 927,166 | 127.17M | Jun 29, 2026 |